Abstract:BACKGROUND:Ceramide plays critical roles in cell proliferation, senescence and apoptosis, and is implicated in neurodegenerative diseases, etc. To clarify if ceramide plays some roles in retinal diseases, we established in vivo and in vitro retinal injury models with ceramide 2 (C2) treatment. In addition, Erythropoietin (EPO), which showed protective effects on retinal cells and blood-retinal barrier (BRB), was also tested for its protection and possible mechanism(s) in these models.METHODS:Male Sprague-Dawley rats were divided into four groups, i.e., normal control, vehicle control, C2 treatment, and C2+EPO treatment. After intravitreal injection, the rats were examined for eye fundus, electroretinogram, histological study, and immunostaining, etc. In vitro, retinal neuronal cell line (R28) and the primary human retinal microvascular endothelial cells (HRMECs) were treated with C2, cell viability assay, transendothelial electrical resistance (TEER) and BRB-related molecules were studied to test the protective effect of EPO.RESULTS:Intravitreal C2-treatment caused significant vision loss in rats, as reflected by reduced b-wave amplitude, increased TUNEL positive cells and GFAP immunostaining in retina. Another major retinal injury observed was BRB breakdown following C2- treatment. Such C2-induced injuries were further confirmed by in vitro study. When HRMECs were treated with C2, the TEER was significantly reduced. The mechanisms for C2 to induce such injuries might be through evidently increased expressions of the related molecules like plasmalemma vesicle-associated protein (PLVAP or PV-1), ecto- 5'-nucleotidase (CD73) and intercellular adhesion molecule-1 (ICAM-1), as observed in C2-treated R28 cells. All these injuries induced by C2 were significantly prevented by EPO both in vivo and in vitro, and its protective mechanisms here might be, in addition to neuroprotective, closely related to its maintenance of BRB integrity, through reducing the expressions of PV-1, CD73 and ICAM-1.CONCLUSION:C2 could induce severe retinal injury, and such injuries could be effectively prevented by EPO treatment.

Lack of Ceramide Synthase 5 Protects Retinal Ganglion Cells from Ocular Hypertensive Injury

Keratin8 Deficiency Aggravates Retinal Ganglion Cell Damage under Acute Ocular Hypertension

Erythropoietin Protects Retina Against Ceramide 2-Induced Damage in Rat

Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy

Synergistic Protection of Retinal Ganglion Cells (RGCs) by SARM1 Inactivation with CNTF in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy

CREG Protects Retinal Ganglion Cells loss and Retinal Function Impairment Against ischemia-reperfusion Injury in mice via Akt Signaling Pathway

Restored retinal physiology after administration of niacin with citicoline in a mouse model of hypertensive glaucoma

Downregulation of SARM1 Protects Retinal Ganglion Cell Axonal and Somal Degeneration Via JNK Activation in a Glaucomatous Model of Ocular Hypertension

Synaptic Degeneration of Retinal Ganglion Cells in a Rat Ocular Hypertension Glaucoma Model

Retinal ganglion cell loss in an ex vivo mouse model of optic nerve cut is prevented by curcumin treatment

Inhibition of De Novo Ceramide Biosynthesis by FTY720 Protects Rat Retina from Light-Induced Degeneration

Cyclosporine A Protects Retinal Explants against Hypoxia

[Protection of Autoimmunity Induced by Copolymer-1 on Optic Nerve: Experiment with Rat Glaucoma Models].

Elevation of P-Nr2as1232 by Cdk5/p35 Contributes to Retinal Ganglion Cell Apoptosis in a Rat Experimental Glaucoma Model

Progressive Degeneration Of Retinal And Superior Collicular Functions In Mice With Sustained Ocular Hypertension

Oxidative Stress Elicited by Modifying the Ceramide Acyl Chain Length Reduces the Rate of Clathrin-Mediated Endocytosis

Insulin or bFGF and C2 ceramide increase newborn rat retinal ganglion cell survival rate

Neuronal p58IPK Protects Retinal Ganglion Cells Independently of Macrophage/Microglia Activation in Ocular Hypertension

Short-Term Omega-3 Supplementation Modulates Novel Neurovascular and Fatty Acid Metabolic Proteome Changes in the Retina and Ophthalmic Artery of Mice with Targeted Cyp2c44 Gene Deletion

Small molecule SIRT1 activators counteract oxidative stress-induced inflammasome activation and nucleolar stress in retinal degeneration

Roles of PI3K and JAK pathways in viability of retinal ganglion cells after acute elevation of intraocular pressure in rats with different autoimmune backgrounds